Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Croat Med J. 2003 Aug;44(4):412-7.

Dual reporter transgene driven by 2.3Col1a1 promoter is active in differentiated osteoblasts.

Author information

  • 1Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT, USA. ingamarijanovic@hotmail.com
  • 2U CT Health Ctr, Farmington

Abstract

AIM:

As quantitative and spatial analyses of promoter reporter constructs are not easily performed in intact bone, we designed a reporter gene specific to bone, which could be analyzed both visually and quantitatively by using chloramphenicol acetyltransferase (CAT) and a cyan version of green fluorescent protein (GFPcyan), driven by a 2.3-kb fragment of the rat collagen promoter (Col2.3).

METHODS:

The construct Col2.3CATiresGFPcyan was used for generating transgenic mice. Quantitative measurement of promoter activity was performed by CAT analysis of different tissues derived from transgenic animals; localization was performed by visualized GFP in frozen bone sections. To assess transgene expression during in vitro differentiation, marrow stromal cell and neonatal calvarial osteoblast cultures were analyzed for CAT and GFP activity.

RESULTS:

In mice, CAT activity was detected in the calvaria, long bone, teeth, and tendon, whereas histology showed that GFP expression was limited to osteoblasts and osteocytes. In cell culture, increased activity of CAT correlated with increased differentiation, and GFP activity was restricted to mineralized nodules.

CONCLUSION:

The concept of a dual reporter allows a simultaneous visual and quantitative analysis of transgene activity in bone.

PMID:
12950143
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for University of Zagreb School of Medicine
    Loading ...
    Write to the Help Desk